FivepHusion is a global advanced clinical-stage biotechnology company focused on optimizing chemotherapy to improve patient treatment outcomes and quality of life. They are developing Deflexifol™, a novel anti-cancer drug reformulation addressing standard chemotherapy"s safety and efficacy limitations to improve anti-tumor activity. Used to treat solid tumors such as colorectal, pancreatic, and breast cancers, this all-in-one formulation delivers both agents simultaneously at a physiological pH, enhancing tolerability, safety, and anti-tumor effectiveness.
